The bracket is here!
Below you will find the 2021 RheumMadness Bracket and additional resources for learning about each team, including scouting reports and key references for each topic.
Click here for a downloadable (and larger) PDF of the bracket
***Scouting Reports Coming Soon***
Rheumatology fellowship programs from all over the U.S. are collaborating to create scouting reports for each team so you can learn about each topic and consider their strengths and weaknesses in the tournament. These reports will be posted here by March 14, 2021. The programs participating this year include:
- Allegheny Health Network
- Duke University
- Loma Linda University
- Massachusetts General Hospital
- Medical College of Wisconsin
- Medical University of South Carolina
- Northwestern University
- Ochsner Medical Center
- University of Chicago
- University of Colorado
- University of Kentucky College of Medicine
- University of North Carolina
- Vanderbilt University
- Wake Forest School of Medicine
Can’t wait?
If you just can’t wait to start learning about these teams, each is based on one or more manuscripts from the last year. These are cited below along with a link to their pubmed page so you can start reading! In addition, the RheumMadness leadership team has made an example scouting report for VEXAS which you can review now.
Belimumab for Lupus Nephritis Scouting report: available 3/15 Reference: Furie et al. NEJM.2020;383(12):1117-28 (pubmed link)
Anifrolumab for SLE Scouting report: available 3/15 Reference(s): TULIP-1 and TULIP-2 trials (click for links)
PEXIVAS in ANCA Vasculitis Scouting report: available 3/15 Reference: Walsh et al. NEJM.2020;382(7):622-31 (pubmed link)
Avacopan in ANCA Vasculitis Scouting report: available 3/15 Reference: Jayne et al. NEJM.2021;384:599-609 (NEJM link)
IgG4-RD Classification Criteria Scouting report: available 3/15 Reference: Wallace et al. A&R.2020;72(1):7-19 (pubmed link)
Relapsing Polychondritis (RP) Subtypes Scouting report: available 3/15 Reference: Ferrada et al. A&R.2020;72(8):1396-1402 (pubmed link)
Anti-CD38 in Refractory SLE Scouting report: available 3/15 Reference: Ostendorf et al. NEJM.2020;383(12):1149-55 (pubmed link)
VEXAS Scouting report: Click here to read! Reference: Beck et al, NEJM.2020;383:2628-38 (pubmed link)
SEMIRA Study in RA Scouting report: available 3/15 Reference: Burmester et al. Lancet.2020;396(10246):267-76 (pubmed link)
Harms of Short Term Steroids Scouting report: available 3/15 Reference: Yao et al. Ann Intern Med.2020;173(5):325-30 (pubmed link)
UK FROST Trial for Frozen Shoulder Scouting report: available 3/15 Reference: Rangan et al. Lancet.2020;396(10256):977-89 (pubmed link)
PT vs. GC Injection for Knee Osteoarthritis Scouting report: available 3/15 Reference: Deyle et al. NEJM.2020;382(15):1420-29 (pubmed link)
PRIME Cells in RA Scouting report: available 3/15 Reference: Orange et al. NEJM.2020;383(3):218-28 (pubmed link)
Synovial B Cells and Therapy Response in RA Scouting report: available 3/15 Reference: Humby et al. Lancet.2021;397(10271):305-17 (pubmed link)
FAST Study in Gout Scouting report: available 3/15 Reference: Mackenzie et al. Lancet.2020;396(10264):1745-57 (pubmed link)
ACR 2020 Gout Guidelines Scouting report: available 3/15 Reference: Fitzgerald et al. AC&R.2020;72(6):744-60 (pubmed link)
